OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, et al.
Gastroenterology (2021) Vol. 161, Iss. 1, pp. 66-80.e8
Open Access | Times Cited: 138
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, et al.
Gastroenterology (2021) Vol. 161, Iss. 1, pp. 66-80.e8
Open Access | Times Cited: 138
Showing 1-25 of 138 citing articles:
Coeliac disease
Carlo Catassi, Elena F. Verdú, Julio C. Bai, et al.
The Lancet (2022) Vol. 399, Iss. 10344, pp. 2413-2426
Closed Access | Times Cited: 280
Carlo Catassi, Elena F. Verdú, Julio C. Bai, et al.
The Lancet (2022) Vol. 399, Iss. 10344, pp. 2413-2426
Closed Access | Times Cited: 280
The global burden of coeliac disease: opportunities and challenges
Govind Makharia, Prashant Singh, Carlo Catassi, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 5, pp. 313-327
Closed Access | Times Cited: 87
Govind Makharia, Prashant Singh, Carlo Catassi, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 5, pp. 313-327
Closed Access | Times Cited: 87
Therapeutic induction of antigen-specific immune tolerance
Jessica E. Kenison, Nikolas A. Stevens, Francisco J. Quintana
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 338-357
Open Access | Times Cited: 50
Jessica E. Kenison, Nikolas A. Stevens, Francisco J. Quintana
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 338-357
Open Access | Times Cited: 50
Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis
Zhihua Wang, Xi Zhang, Shu Lu, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 3, pp. 290-306
Open Access | Times Cited: 42
Zhihua Wang, Xi Zhang, Shu Lu, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 3, pp. 290-306
Open Access | Times Cited: 42
New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease
Valérie Abadie, Arnold Han, Bana Jabrì, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 4-22
Closed Access | Times Cited: 17
Valérie Abadie, Arnold Han, Bana Jabrì, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 4-22
Closed Access | Times Cited: 17
Celiac Disease: Beyond Diet and Food Awareness
Lourdes Herrera‐Quintana, Beatriz Navajas-Porras, Héctor Vázquez‐Lorente, et al.
Foods (2025) Vol. 14, Iss. 3, pp. 377-377
Open Access | Times Cited: 2
Lourdes Herrera‐Quintana, Beatriz Navajas-Porras, Héctor Vázquez‐Lorente, et al.
Foods (2025) Vol. 14, Iss. 3, pp. 377-377
Open Access | Times Cited: 2
Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
Laura Passeri, Marta Fortunato, Virginia Bassi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8415-8415
Open Access | Times Cited: 60
Laura Passeri, Marta Fortunato, Virginia Bassi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8415-8415
Open Access | Times Cited: 60
Immunopathogenesis and environmental triggers in coeliac disease
Anaïs Levescot, Georgia Malamut, Nadine Cerf–Bensussan
Gut (2022) Vol. 71, Iss. 11, pp. 2337-2349
Open Access | Times Cited: 56
Anaïs Levescot, Georgia Malamut, Nadine Cerf–Bensussan
Gut (2022) Vol. 71, Iss. 11, pp. 2337-2349
Open Access | Times Cited: 56
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial
Joseph A. Murray, Dina Wassaf, Karen Dunn, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 735-747
Closed Access | Times Cited: 35
Joseph A. Murray, Dina Wassaf, Karen Dunn, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 735-747
Closed Access | Times Cited: 35
Impact of nanotechnology on the oral delivery of phyto-bioactive compounds
Hamdi Nsairat, Zainab Lafi, Mazen Al-Sulaibi, et al.
Food Chemistry (2023) Vol. 424, pp. 136438-136438
Closed Access | Times Cited: 30
Hamdi Nsairat, Zainab Lafi, Mazen Al-Sulaibi, et al.
Food Chemistry (2023) Vol. 424, pp. 136438-136438
Closed Access | Times Cited: 30
New Developments in Celiac Disease Treatment
Mariana Verdelho Machado
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 945-945
Open Access | Times Cited: 28
Mariana Verdelho Machado
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 945-945
Open Access | Times Cited: 28
Celiac disease: mechanisms and emerging therapeutics
Harrison A. Besser, Chaitan Khosla
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 949-962
Closed Access | Times Cited: 24
Harrison A. Besser, Chaitan Khosla
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 949-962
Closed Access | Times Cited: 24
How Future Pharmacologic Therapies for Celiac Disease Will Complement the Gluten-Free Diet
Valentina Discepolo, Ciarán P. Kelly, Frits Koning, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 90-103
Open Access | Times Cited: 15
Valentina Discepolo, Ciarán P. Kelly, Frits Koning, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 90-103
Open Access | Times Cited: 15
Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 12
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 12
Therapeutic synthetic and natural materials for immunoengineering
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions
Ludvig M. Sollid
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 335-347
Closed Access | Times Cited: 10
Ludvig M. Sollid
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 335-347
Closed Access | Times Cited: 10
New developments in celiac disease treatments
Franziska Buriánek, Christian Gege, Petar Marinković
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104113-104113
Open Access | Times Cited: 9
Franziska Buriánek, Christian Gege, Petar Marinković
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104113-104113
Open Access | Times Cited: 9
Coeliac disease: complications and comorbidities
Jonas F. Ludvigsson, Jialu Yao, Benjamin Lebwohl, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
Jonas F. Ludvigsson, Jialu Yao, Benjamin Lebwohl, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis
Laila M. Rad, Kevin R. Hughes, Sydney N. Wheeler, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access | Times Cited: 1
Laila M. Rad, Kevin R. Hughes, Sydney N. Wheeler, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access | Times Cited: 1
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
Yang Liu, Jun Li, Baowen Zhang, et al.
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Yang Liu, Jun Li, Baowen Zhang, et al.
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment
Elena F. Verdú, Detlef Schuppan
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1395-1411.e4
Closed Access | Times Cited: 51
Elena F. Verdú, Detlef Schuppan
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1395-1411.e4
Closed Access | Times Cited: 51
Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance
Liam M. Casey, Kevin R. Hughes, Michael N. Saunders, et al.
Biomaterials (2022) Vol. 283, pp. 121457-121457
Open Access | Times Cited: 33
Liam M. Casey, Kevin R. Hughes, Michael N. Saunders, et al.
Biomaterials (2022) Vol. 283, pp. 121457-121457
Open Access | Times Cited: 33
Type 1 regulatory T cell-mediated tolerance in health and disease
Robert A. Freeborn, Steven Strubbe, Maria Grazia Roncarolo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Robert A. Freeborn, Steven Strubbe, Maria Grazia Roncarolo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Immunization using ApoB-100 peptide–linked nanoparticles reduces atherosclerosis
Kuang‐Yuh Chyu, Xiaoning Zhao, Jianchang Zhou, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 31
Kuang‐Yuh Chyu, Xiaoning Zhao, Jianchang Zhou, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 31
Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis
Amee Sonigra, Hendrik J. Nel, Pascale Wehr, et al.
JCI Insight (2022) Vol. 7, Iss. 20
Open Access | Times Cited: 31
Amee Sonigra, Hendrik J. Nel, Pascale Wehr, et al.
JCI Insight (2022) Vol. 7, Iss. 20
Open Access | Times Cited: 31
